Impact Ratings Show Cancer Journal Continues to Outperform
P站视频
The annual scientific and clinical Journal Impact Factors were released on June 30, and the P站视频’s ?outperformed. ?The CA impact factor climbed from 292.3 last year to a staggering 508.7 and remains the highest-rated oncology journal in the world.
CA?is not only the leading journal for the entire oncology subject category but ranks highest for all 254 categories included in the?.?
CA’s score is due mainly to the global cancer statistics article and the annual report on cancer statistics, two of the most cited cancer articles in the world. These citations, factored along with a small number of publications, accounts for?CA’s high score. Other highly cited manuscripts include the P站视频 screening guidelines, cancer statistics for special populations, and comprehensive reviews.
Our journal??ranked No. 1 in the field of cytopathology. It scored 5.284. Our journal??scored 6.860. Each journal falls within the top quartile of its subject category.?
Bill Cance, MD, our chief medical and scientific officer, is editor in chief of?CA: A Cancer Journal for Clinicians, and?Ted Gansler,?MD, MBA, MPH, is its editor.?
- Reviewed by
- Helpful resources
The P站视频 medical and editorial content team
Our team is made up of doctors and?oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
P站视频 news stories are copyrighted material and are not intended to be used as . For reprint requests, please see our Content?Usage Policy.